DOI 10.1016/j.inpm.2023.100255
Treatment of chest wall pain syndrome from oncologic etiology with neuromodulation: A narrative review.
Аннотация
Pain affects 50% of patients with cancer. Cancer-related pain occurs from tumor invasion as well as a sequela from cancer treatment. Despite numerous and often significant side effects, opioid, and neuropathic pain medications remain the mainstays of treatment for cancer-related pain. Neuromodulation-based treatment approaches including SCS, DRGS, and PNS are becoming increasingly common in the cancer pain landscape. In this narrative review, we present 11 case reports and case series that highlight the usefulness of neuromodulation for the treatment of chest wall pain from various cancer-related pathologies. Of the 34 patients included in these reports, 30 patients (88.25%) derived meaningful pain relief with the use of neuromodulation-based approaches. In addition, a majority of patients were able to reduce or eliminate their opioid requirements. This review provides early evidence that neuromodulation can be an effective treatment option for the treatment of cancer-related chest wall pain and set the backdrop for future clinical trials.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.